TELA Financial Statements

Balance sheet, income statement, cash flow, and dividends for Tela Bio Inc (TELA).


$118.95M Market Cap.

As of 03/21/2025 5:00 PM ET (MRY) • Disclaimer

TELA Market Cap. (MRY)


TELA Shares Outstanding (MRY)


TELA Assets (MRY)


Total Assets

$86.57M

Total Liabilities

$58.11M

Total Investments

$0

TELA Income (MRY)


Revenue

$69.30M

Net Income

-$37.84M

Operating Expense

$88.18M

TELA Cash Flow (MRY)


CF Operations

-$41.59M

CF Investing

$4.45M

CF Financing

$43.06M

TELA Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

TELA Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$86,570,000 (10.92%)

$78,048,000 (15.02%)

$67,855,000 (8.49%)

$62,544,000 (-27.66%)

Assets Current

$78,071,000 (8.85%)

$71,726,000 (14.86%)

$62,447,000 (5.74%)

$59,055,000 (-29.04%)

Assets Non-Current

$8,499,000 (34.44%)

$6,322,000 (16.90%)

$5,408,000 (55.00%)

$3,489,000 (7.92%)

Goodwill & Intangible Assets

$1,739,000 (-17.93%)

$2,119,000 (-15.21%)

$2,499,000 (8.51%)

$2,303,000 (-11.66%)

Shareholders Equity

$28,458,000 (50.72%)

$18,881,000 (31.99%)

$14,305,000 (-28.82%)

$20,098,000 (-59.01%)

Property Plant & Equipment Net

$4,079,000 (3.58%)

$3,938,000 (35.37%)

$2,909,000 (145.28%)

$1,186,000 (89.46%)

Cash & Equivalents

$52,935,000 (12.64%)

$46,994,000 (11.84%)

$42,019,000 (-4.35%)

$43,931,000 (-40.95%)

Accumulated Other Comprehensive Income

$90,000 (-1.10%)

$91,000 (-39.33%)

$150,000 (388.46%)

-$52,000 (26.76%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$12,781,000 (-2.89%)

$13,162,000 (11.62%)

$11,792,000 (53.98%)

$7,658,000 (96.01%)

Trade & Non-Trade Receivables

$10,098,000 (3.71%)

$9,737,000 (47.06%)

$6,621,000 (56.38%)

$4,234,000 (57.81%)

Trade & Non-Trade Payables

$2,147,000 (28.79%)

$1,667,000 (8.67%)

$1,534,000 (-36.45%)

$2,414,000 (270.25%)

Accumulated Retained Earnings (Deficit)

-$358,730,000 (-11.79%)

-$320,889,000 (-17.02%)

-$274,225,000 (-19.27%)

-$229,929,000 (-16.92%)

Tax Assets

$140,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$41,124,000 (1.50%)

$40,515,000 (1.50%)

$39,916,000 (26.75%)

$31,491,000 (2.15%)

Debt Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$41,124,000 (1.50%)

$40,515,000 (1.50%)

$39,916,000 (26.75%)

$31,491,000 (2.15%)

Total Liabilities

$58,112,000 (-1.78%)

$59,167,000 (10.49%)

$53,550,000 (26.16%)

$42,446,000 (13.39%)

Liabilities Current

$15,598,000 (-8.07%)

$16,967,000 (36.80%)

$12,403,000 (17.29%)

$10,575,000 (60.11%)

Liabilities Non-Current

$42,514,000 (0.74%)

$42,200,000 (2.56%)

$41,147,000 (29.10%)

$31,871,000 (3.39%)

TELA Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$69,300,000 (18.56%)

$58,453,000 (41.13%)

$41,418,000 (40.58%)

$29,463,000 (61.77%)

Cost of Revenue

$22,812,000 (24.38%)

$18,341,000 (27.60%)

$14,374,000 (34.97%)

$10,650,000 (52.60%)

Selling General & Administrative Expense

$79,370,000 (6.44%)

$74,568,000 (30.56%)

$57,114,000 (37.55%)

$41,521,000 (28.73%)

Research & Development Expense

$8,813,000 (-8.38%)

$9,619,000 (7.63%)

$8,937,000 (32.54%)

$6,743,000 (58.47%)

Operating Expenses

$88,183,000 (4.75%)

$84,187,000 (27.46%)

$66,051,000 (36.85%)

$48,264,000 (32.20%)

Interest Expense

$5,290,000 (1.28%)

$5,223,000 (28.93%)

$4,051,000 (12.62%)

$3,597,000 (0.93%)

Income Tax Expense

-$144,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$37,841,000 (18.91%)

-$46,664,000 (-5.35%)

-$44,296,000 (-33.12%)

-$33,276,000 (-15.57%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$37,841,000 (18.91%)

-$46,664,000 (-5.35%)

-$44,296,000 (-33.12%)

-$33,276,000 (-15.57%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$37,841,000 (18.91%)

-$46,664,000 (-5.35%)

-$44,296,000 (-33.12%)

-$33,276,000 (-15.57%)

Weighted Average Shares

$28,526,441 (24.74%)

$22,868,663 (40.58%)

$16,267,678 (12.40%)

$14,473,213 (11.90%)

Weighted Average Shares Diluted

$28,526,441 (24.74%)

$22,868,663 (40.58%)

$16,267,678 (12.40%)

$14,473,213 (11.90%)

Earning Before Interest & Taxes (EBIT)

-$32,695,000 (21.10%)

-$41,441,000 (-2.97%)

-$40,245,000 (-35.60%)

-$29,679,000 (-17.63%)

Gross Profit

$46,488,000 (15.90%)

$40,112,000 (48.32%)

$27,044,000 (43.75%)

$18,813,000 (67.46%)

Operating Income

-$41,695,000 (5.40%)

-$44,075,000 (-12.99%)

-$39,007,000 (-32.45%)

-$29,451,000 (-16.52%)

TELA Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$4,451,000 (843.07%)

-$599,000 (68.00%)

-$1,872,000 (-198.56%)

-$627,000 (-106.87%)

Net Cash Flow from Financing

$43,057,000 (-6.94%)

$46,267,000 (13.26%)

$40,852,000 (6883.25%)

$585,000 (-98.68%)

Net Cash Flow from Operations

-$41,595,000 (-1.81%)

-$40,857,000 (-0.27%)

-$40,748,000 (-33.90%)

-$30,432,000 (-24.44%)

Net Cash Flow / Change in Cash & Cash Equivalents

$5,941,000 (19.42%)

$4,975,000 (360.20%)

-$1,912,000 (93.72%)

-$30,463,000 (-204.71%)

Net Cash Flow - Business Acquisitions and Disposals

$5,440,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$989,000 (-65.11%)

-$599,000 (31.31%)

-$872,000 (-39.07%)

-$627,000 (-275.45%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$6,540,000 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$43,426,000 (-6.72%)

$46,556,000 (35.07%)

$34,469,000 (5792.14%)

$585,000 (-98.68%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$28,000 (-82.93%)

$164,000 (213.89%)

-$144,000 (-1409.09%)

$11,000 (-35.29%)

Share Based Compensation

$4,362,000 (-13.31%)

$5,032,000 (26.15%)

$3,989,000 (8.96%)

$3,661,000 (77.89%)

Depreciation Amortization & Accretion

$1,012,000 (25.25%)

$808,000 (-31.93%)

$1,187,000 (121.87%)

$535,000 (1.90%)

TELA Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

67.10% (-2.19%)

68.60% (5.05%)

65.30% (2.19%)

63.90% (3.57%)

Profit Margin

-54.60% (31.58%)

-79.80% (25.35%)

-106.90% (5.31%)

-112.90% (28.59%)

EBITDA Margin

-45.70% (34.24%)

-69.50% (26.30%)

-94.30% (4.65%)

-98.90% (27.06%)

Return on Average Equity (ROAE)

-383.80% (-90.38%)

-201.60% (47.54%)

-384.30% (-259.49%)

-106.90% (-79.06%)

Return on Average Assets (ROAA)

-55.70% (4.95%)

-58.60% (15.93%)

-69.70% (-48.30%)

-47.00% (-36.63%)

Return on Sales (ROS)

-47.20% (33.43%)

-70.90% (27.06%)

-97.20% (3.48%)

-100.70% (27.29%)

Return on Invested Capital (ROIC)

-56.80% (27.92%)

-78.80% (8.80%)

-86.40% (-3.47%)

-83.50% (-19.29%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-2.27 (30.02%)

-3.25 (23.25%)

-4.23 (24.03%)

-5.57 (17.48%)

Price to Sales Ratio (P/S)

1.24 (-52.01%)

2.59 (-42.66%)

4.52 (-28.16%)

6.29 (-41.13%)

Price to Book Ratio (P/B)

4.18 (-51.32%)

8.59 (-44.25%)

15.4 (66.74%)

9.24 (108.65%)

Debt to Equity Ratio (D/E)

2.04 (-34.84%)

3.13 (-16.27%)

3.74 (77.23%)

2.11 (176.44%)

Earnings Per Share (EPS)

-1.33 (34.80%)

-2.04 (25.00%)

-2.72 (-18.26%)

-2.3 (-3.14%)

Sales Per Share (SPS)

2.43 (-4.97%)

2.56 (0.39%)

2.55 (25.05%)

2.04 (44.60%)

Free Cash Flow Per Share (FCFPS)

-1.49 (17.65%)

-1.81 (29.12%)

-2.56 (-19.20%)

-2.15 (-12.71%)

Book Value Per Share (BVPS)

1 (20.82%)

0.83 (-6.03%)

0.88 (-36.72%)

1.39 (-63.35%)

Tangible Assets Book Value Per Share (TABVPS)

2.97 (-10.42%)

3.32 (-17.37%)

4.02 (-3.46%)

4.16 (-35.80%)

Enterprise Value Over EBIT (EV/EBIT)

-4 (-33.33%)

-3 (40.00%)

-5 (16.67%)

-6 (14.29%)

Enterprise Value Over EBITDA (EV/EBITDA)

-4.49 (-26.53%)

-3.55 (32.63%)

-5.27 (5.94%)

-5.6 (16.73%)

Asset Turnover

1.02 (39.10%)

0.73 (12.58%)

0.65 (56.73%)

0.42 (91.71%)

Current Ratio

5 (18.41%)

4.23 (-16.05%)

5.04 (-9.83%)

5.58 (-55.68%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$42,584,000 (-2.72%)

-$41,456,000 (0.39%)

-$41,620,000 (-34.00%)

-$31,059,000 (-26.14%)

Enterprise Value (EV)

$142,357,098 (-1.33%)

$144,276,876 (-29.92%)

$205,870,168 (26.05%)

$163,324,696 (-1.77%)

Earnings Before Tax (EBT)

-$37,985,000 (18.60%)

-$46,664,000 (-5.35%)

-$44,296,000 (-33.12%)

-$33,276,000 (-15.57%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$31,683,000 (22.03%)

-$40,633,000 (-4.03%)

-$39,058,000 (-34.02%)

-$29,144,000 (-17.97%)

Invested Capital

$57,422,000 (9.41%)

$52,483,000 (3.21%)

$50,850,000 (36.60%)

$37,226,000 (10.53%)

Working Capital

$62,473,000 (14.09%)

$54,759,000 (9.42%)

$50,044,000 (3.23%)

$48,480,000 (-36.73%)

Tangible Asset Value

$84,831,000 (11.72%)

$75,929,000 (16.18%)

$65,356,000 (8.49%)

$60,241,000 (-28.16%)

Market Capitalization

$118,953,098 (-26.62%)

$162,115,876 (-26.42%)

$220,330,168 (18.68%)

$185,645,696 (-14.47%)

Average Equity

$9,860,000 (-57.40%)

$23,144,750 (100.81%)

$11,525,500 (-62.97%)

$31,120,750 (-35.50%)

Average Assets

$67,906,750 (-14.73%)

$79,634,750 (25.36%)

$63,526,500 (-10.36%)

$70,867,750 (-15.43%)

Invested Capital Average

$57,595,750 (9.55%)

$52,577,000 (12.92%)

$46,562,500 (31.01%)

$35,541,000 (-1.39%)

Shares

39,388,443 (60.84%)

24,488,803 (27.82%)

19,159,145 (32.10%)

14,503,570 (0.49%)